Dravet Syndrome Global Clinical Trials Review 2024
| HTDIX Fund | USD 13.43 0.05 0.37% |
Slightly above 54% of Hanlon Tactical's investor base is interested to short. The analysis of overall sentiment of trading Hanlon Tactical Dividend mutual fund suggests that many investors are impartial at this time. Hanlon Tactical's investing sentiment can be driven by a variety of factors including economic data, Hanlon Tactical's earnings reports, geopolitical events, and overall market trends.
Hanlon |
Company Coverage includes Jazz Pharmaceuticals, UCB, Takeda Pharmaceutical, Biocodex, Longboard Pharmaceuticals, Stoke Therapeutics, Thermo Fisher Scientific, Harmony Biosciences Holdings, Ovid Therapeutics and Sage Therapeutics.Dublin, Dec. 26, 2024 -- The Dravet Syndrome - Global Clinical Trials Review, 2024 clinical trials has been added to ResearchAndMarkets.coms offering.The clinical trial report provides an overview of Dravet Syndr
Read at finance.yahoo.com
 |
Hanlon Tactical Fundamental Analysis
We analyze Hanlon Tactical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hanlon Tactical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hanlon Tactical based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Hanlon Tactical is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Hanlon Tactical Dividend Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hanlon Tactical mutual fund to make a market-neutral strategy. Peer analysis of Hanlon Tactical could also be used in its relative valuation, which is a method of valuing Hanlon Tactical by comparing valuation metrics with similar companies.
Peers
Hanlon Tactical Related Equities
| LVAQX | Lsv Small | 0.70 | ||||
| MAVKX | Mutual Of | 0.34 | ||||
| RSPMX | Victory Rs | 0.32 | ||||
| VISVX | Vanguard Small-cap | 0.50 | ||||
| AVCNX | American Century | 0.64 | ||||
| QRSVX | Queens Road | 0.76 | ||||
| RYAHX | Mid-cap 15x | 0.93 |
Other Information on Investing in Hanlon Mutual Fund
Hanlon Tactical financial ratios help investors to determine whether Hanlon Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hanlon with respect to the benefits of owning Hanlon Tactical security.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |